Learn More
CERILLIANT™ Dehydro Aripiprazole-D8 Solution, 100 μg/mL (Methanol with 5% 1 N HCl), Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco D1781ML
Description
This stable-labeled internal standard is suitable for use in LC/MS or GC/MS applications including forensic or clinical toxicology analysis and urine drug testing. Dehydro Aripiprazole is the primary, active metabolite of aripiprazole, marketed as the atypical antipsychotic Abilify™ for the treatment of schizophrenia, bipolar disorder, and clinical depression.
Specifications
| 67-56-1 | |
| 100 μg/mL (methanol with 5% 1 N HCl) | |
| Ampule | |
| 9.7°C (49.5°F) - closed cup |
| C23H17D8Cl2N3O2 | |
| 454.42 | |
| 1 mL |
Safety and Handling
H331-H370
H311
Recommended Storage : -20°C
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
CERILLIANT is a registered trademark of Cerilliant Corporation